Mary A. Wood

1.9k total citations · 1 hit paper
24 papers, 1.3k citations indexed

About

Mary A. Wood is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mary A. Wood has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mary A. Wood's work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers) and Cancer Genomics and Diagnostics (4 papers). Mary A. Wood is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers) and Cancer Genomics and Diagnostics (4 papers). Mary A. Wood collaborates with scholars based in United States, Australia and Canada. Mary A. Wood's co-authors include Reid F. Thompson, Abhinav Nellore, Julianne K. David, Benjamin R. Weeder, Austin Nguyen, Sean K. Maden, Charles S. Yeung, Jennifer A. Kozak, Laurel L. Schafer and David C. Leitch and has published in prestigious journals such as Nature, Angewandte Chemie International Edition and Circulation.

In The Last Decade

Mary A. Wood

22 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Androgen receptor activity in T cells limits checkpoint blockade efficacy

2022 233 citations Xiangnan Guan, Fanny Polesso et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary A. Wood United States	13	331	318	309	275	247	24	1.3k
Chitra Krishnamurti United States	18	131 0.4×	173 0.5×	284 0.9×	180 0.7×	118 0.5×	39	1.1k
Javier Gómez United States	18	116 0.4×	30 0.1×	361 1.2×	270 1.0×	373 1.5×	51	1.0k
Shuang Qi China	15	60 0.2×	182 0.6×	144 0.5×	163 0.6×	101 0.4×	56	751
Michelly Cristiny Pereira Brazil	18	251 0.8×	84 0.3×	105 0.3×	306 1.1×	76 0.3×	81	895
Qin Lu China	16	99 0.3×	98 0.3×	117 0.4×	181 0.7×	179 0.7×	50	652
Alice Zoccoli Italy	19	66 0.2×	190 0.6×	336 1.1×	306 1.1×	206 0.8×	34	956
B.M.J. Cantwell United Kingdom	19	70 0.2×	29 0.1×	421 1.4×	338 1.2×	138 0.6×	52	1.1k
Akiko Kondo Japan	19	41 0.1×	53 0.2×	73 0.2×	417 1.5×	34 0.1×	48	1000
Rosana Eisenberg United States	23	124 0.4×	68 0.2×	517 1.7×	899 3.3×	790 3.2×	43	2.1k
M. Shelley United Kingdom	19	125 0.4×	48 0.2×	364 1.2×	270 1.0×	503 2.0×	34	1.8k

Countries citing papers authored by Mary A. Wood

Since Specialization

Citations

This map shows the geographic impact of Mary A. Wood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary A. Wood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary A. Wood more than expected).

Fields of papers citing papers by Mary A. Wood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary A. Wood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary A. Wood. The network helps show where Mary A. Wood may publish in the future.

Co-authorship network of co-authors of Mary A. Wood

This figure shows the co-authorship network connecting the top 25 collaborators of Mary A. Wood. A scholar is included among the top collaborators of Mary A. Wood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary A. Wood. Mary A. Wood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

David, Julianne K., Sean K. Maden, Mary A. Wood, Reid F. Thompson, & Abhinav Nellore. (2022). Retained introns in long RNA-seq reads are not reliably detected in sample-matched short reads. Genome biology. 23(1). 240–240. 11 indexed citations

Guan, Xiangnan, Fanny Polesso, Chaojie Wang, et al.. (2022). Androgen receptor activity in T cells limits checkpoint blockade efficacy. Nature. 606(7915). 791–796. 233 indexed citations breakdown →

Weeder, Benjamin R., et al.. (2021). pepsickle rapidly and accurately predicts proteasomal cleavage sites for improved neoantigen identification. Bioinformatics. 37(21). 3723–3733. 6 indexed citations

Gordon, Naheema S., Laura Baxter, Anshita Goel, et al.. (2021). Urine DNA for monitoring chemoradiotherapy response in muscle‐invasive bladder cancer: a pilot study. British Journal of Urology. 129(1). 32–34. 3 indexed citations

Nguyen, Austin, Julianne K. David, Sean K. Maden, et al.. (2020). Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2. Journal of Virology. 94(13). 360 indexed citations

Wood, Mary A., Benjamin R. Weeder, Julianne K. David, Abhinav Nellore, & Reid F. Thompson. (2020). Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival. Genome Medicine. 12(1). 33–33. 69 indexed citations

Graff, Julie N., Tomasz M. Beer, Joshi J. Alumkal, et al.. (2020). A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone. Journal for ImmunoTherapy of Cancer. 8(2). e000642–e000642. 87 indexed citations

Wood, Mary A., Austin Nguyen, Adam J. Struck, et al.. (2019). neoepiscope improves neoepitope prediction with multivariant phasing. Bioinformatics. 36(3). 713–720. 20 indexed citations

Graff, Julie N., Amy E. Moran, Rachel Slottke, et al.. (2019). Phase II study of pembrolizumab with enzalutamide (Enz) in metastatic, castration-resistant prostate cancer (mCRPC): 30 patient expansion with examination of tumour-infiltrating immune cells and fecal microbiota. Annals of Oncology. 30. v329–v329. 5 indexed citations

10.

Wood, Mary A., Austin Nguyen, Adam J. Struck, et al.. (2018). Population-level distribution and putative immunogenicity of cancer neoepitopes. BMC Cancer. 18(1). 414–414. 22 indexed citations

11.

Graff, Julie N., Joshi J. Alumkal, Reid F. Thompson, et al.. (2018). Pembrolizumab (Pembro) plus enzalutamide (Enz) in metastatic castration resistant prostate cancer (mCRPC): Extended follow up.. Journal of Clinical Oncology. 36(15_suppl). 5047–5047. 27 indexed citations

12.

Wood, Mary A., David C. Leitch, Charles S. Yeung, Jennifer A. Kozak, & Laurel L. Schafer. (2006). Chiral Neutral Zirconium Amidate Complexes for the Asymmetric Hydroamination of Alkenes. Angewandte Chemie International Edition. 46(3). 354–358. 247 indexed citations

13.

Reeves, William C., James W. Griffith, Mary A. Wood, & L Whitesell. (1990). Exacerbation of doxorubicin cardiotoxicity by digoxin administration in an experimental rabbit model. International Journal of Cancer. 45(4). 731–736. 12 indexed citations

14.

Pearlman, Stephen A., et al.. (1989). Caffeine Pharmacokinetics in Preterm Infants Older than2 Weeks. Developmental Pharmacology and Therapeutics. 12(2). 65–69. 28 indexed citations

15.

Ward, Robert M., et al.. (1986). Oliguria and Tolazoline Pharmacokinetics in the Newborn. PEDIATRICS. 77(3). 307–315. 11 indexed citations

16.

Bellinger, Mark F., et al.. (1986). Renal Function in the Fetal Lamb: A Chronic Model to Study Physiological Effects of Ureteral Ligation and Deligation. The Journal of Urology. 136(1 Part 2). 225–228. 12 indexed citations

17.

Reeves, William C., et al.. (1985). Coronary artery spasm after abrupt withdrawal of nitroglycerin in rabbits. The American Journal of Cardiology. 55(8). 1066–1069. 14 indexed citations

18.

Reeves, William C., et al.. (1985). Effect of diltiazem and ibuprofen on right ventricular hypertrophy in an experimental model of hypoxic pulmonary hypertension. The American Journal of Cardiology. 56(7). 470–472. 3 indexed citations

19.

Reeves, William C., et al.. (1983). The release of thromboxane A2 and prostacyclin following experimental acute pulmonary embolism. Prostaglandins Leukotrienes and Medicine. 11(1). 1–10. 51 indexed citations

20.

Reeves, William C., David Cunningham, Arthur B. Abt, et al.. (1982). Myocardial hydroxyproline reduced by early administration of methylprednisolone or ibuprofen to rabbits with radiation-induced heart disease.. Circulation. 65(5). 924–927. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact